Bergua Burgues, JMM, Cano-Ferri, I, Martínez-Cuadron, D, Boluda, B, Martínez-Sánchez, P, Rodríguez-Veiga, R, Esteve, J, Vives, S, Serrano, J, Vidriales, M-B, Salamero, O, Carretero, C, Jimenez-Ubieto, A, Casas, I, Cardesa, R, Diaz-Beyá, M, Brunet, S, Benavente, C, Pérez-Simón, JA, Moscardo, F, Aguiar, E, Perez Encinas, M, Martínez, AL, Rguez, C, Cabello, A, Labrador, J, Costilla, LDP
, Sossa, C, Bernal Del Castillo, T, Sanz, MA & Montesinos, P 2019, '
Outcomes after Plerixafor Plus FLAG-IDA (PLERIFLAG) Versus FLAG-IDA +/- Gentuzumab for Adult Patients with First Relapsed/Refractory AML: A Propensity Score Analysis from the Pethema Registry',
Blood.
https://doi.org/10.1182/blood-2019-128568